Increasing Product Launches are Propelling the Growth of the ATP Assays Market in the APAC Region!

The Asia Pacific ATP Assays market is a significant contributor to the global ATP Assays market, which is expected to grow significantly during the forecast period. The rising prevalence of infectious diseases such as dengue, along with the presence of emerging economies and increasing efforts for drug discovery and research in the region are the major factors responsible for the growth of the ATP assays market in the region. For instance, Thermo Fisher Scientific is operating in the region to provide ATP-based assays required for drug research. Further, improving healthcare infrastructure and increasing environmental concerns are other factors responsible for the increasing adoption of various testing techniques including ATP assays.

Access sample report (including graphs, charts, and figures): https://univdatos.com/report/atp-assays-market/get-a-free-sample-form.php?product_id=40852

Further, the Asia-Pacific ATP Assays Market is expected to grow at a strong CAGR of 8% during the forecast period (2023-2030). The growing population and rising respiratory diseases among them are the major reason for the market growth of ATP Assays in the Asia-Pacific.

Revenue (2020-2030)- USD Mn

For a detailed analysis of Global ATP Assays Market browse through – https://univdatos.com/report/atp-assays-market/

Based on product, the market is segmented into consumables & accessories, and instruments. As per our analysis, the consumables & accessories segment acquired a major share in 2022. Consumables and accessories are essential components of ATP assays, and they include various reagents, kits, plates, and detection systems. The high usage of consumables & kits in the ATP assays, along with their cost-effectiveness are the major attributing factors to the large share of the segment

Based on the application, the market is segmented into contamination testing, disease testing, drug discovery and development, and others. As per our analysis, the disease testing segment held the dominant share in 2022. The increasing prevalence of chronic diseases, along with the rising awareness about diagnostics are important factors for the dominating share of the segment in the market. For example, as per the World Health Organization, Cardiovascular disease is the leading cause of death worldwide, claiming an estimated 17.9 million lives each year

Global ATP Assays Market Segmentation

Market Insight, by Product